iSpecimen News

iSpecimen | 8-K: Current report

Apr 11 16:15 ET

iSpecimen | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Mar 28 16:55 ET

iSpecimen | 3: Initial statement of beneficial ownership of securities-Director Graham Elizabeth Ames

Mar 26 16:38 ET

iSpecimen | 8-K: Current report

Mar 26 16:16 ET

iSpecimen | 8-K: Current report

Mar 14 09:09 ET

iSpecimen | 10-K: Annual report

Mar 13 17:30 ET

iSpecimen | 8-K: Current report

Mar 5 09:28 ET

iSpecimen | 424B5: Prospectus

Mar 5 09:28 ET

iSpecimen | 8-K: Current report

Feb 15 17:13 ET

iSpecimen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OBF Investments, LLC(9.3%),George H. Scholl(9.3%)

Feb 13 22:15 ET

iSpecimen | 5: Annual statement of changes in beneficial ownership of securities-Director Mock Theresa L

Feb 8 16:25 ET

iSpecimen | 8-K: Current report

Dec 21, 2023 16:15 ET

iSpecimen | 8-K: iSpecimen Reports Third Quarter 2023 Financial and Operating Results

Nov 2, 2023 09:01 ET

iSpecimen: Q3 2023 Earnings Report

Nov 2, 2023 06:30 ET

iSpecimen | 8-K: Current report

Oct 23, 2023 07:45 ET

iSpecimen | 8-K: Current report

Oct 10, 2023 17:29 ET

iSpecimen | 4: Statement of changes in beneficial ownership of securities-Officer Bielak Benjamin

Sep 15, 2023 16:23 ET

iSpecimen | 8-K: Current report

Sep 6, 2023 16:16 ET

iSpecimen | 8-K: iSpecimen Reports Second Quarter 2023 Financial and Operating Results

Aug 2, 2023 09:15 ET

iSpecimen | 10-Q: Q2 2023 Earnings Report

Aug 2, 2023 06:30 ET